Lexology January 16, 2026
On December 31, 2025, the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) announced that that they were issuing a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medication. This was done right in the nick of time, as the prior temporary extension was set to expire at the end of 2025.
The extension allows prior COVID-19-era telemedicine flexibilities to remain in place until December 31, 2026. Namely, health care providers should still expect to be allowed to remotely prescribe Schedule II-V...
Today's Sponsors
Today's Sponsor